MedPath

/Autism Spectrum Disorder(ASD)Hearing Abnormalities Study

Conditions
Autism Spectrum Disorder
Registration Number
NCT03252392
Lead Sponsor
Assiut University
Brief Summary

Co morbidity rates of hearing loss in children with autism spectrum disorder are high and increasing.

Investigators are aiming to:

1. evaluate peripheral auditory and brain stem auditory function in children with autism spectrum disorder.

2. compare communication capabilities in autistic children having hearing abnormalities and autistic children with normal hearing.

Detailed Description

Full audiological evaluation is carried out to all participants including:

* pure tone and speech audiometry.

* Tympanometry and acoustic reflex threshold evaluation.

* Threshold auditory brain stem response for threshold determination in non co operative children not respond to pure tone,speech audiometry.

* Auditory brain stem response for neuro-otologic diagnosis.

* Transient evoked otoacoustic emissions in children proved to have normal hearing to detect minimal cochlear affection .

* Transient evoked otoacoustic emissions with contralateral masking. Communication evaluation is carried out to all participants using arabic language test(kotby et al,1995).

Investigators use childhood autism rating scale for (CARS) for diagnosis of autism spectrum disorder.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Children aged 3-12 years diagnosed to have mild to moderate autism spectrum disorder diagnosed by childhood autism spectrum disorder(CARS 35% or less)
Read More
Exclusion Criteria
  • children with otitis media with effusion.
  • Associated neurological deficit .
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of autistic participants suffering from hearing abnormalities.3 years from october 2017 to october 2020

Invistigators choose autistic children attending phoniatric unit in assiut university from october 2017 to october 2020 as they will go under complete audiological evaluation.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath